1. Janson BJ, Sikder S. Surgical management of pterygium. Ocul Surf. 2014; 12:112–119.
Article
2. Liu D. Conjunctivochalasis. A cause of tearing and its management. Ophthalmic Plast Reconstr Surg. 1986; 2:25–28.
3. Wang Y, Dogru M, Matsumoto Y, et al. The impact of nasal conjunctivochalasis on tear functions and ocular surface findings. Am J Ophthalmol. 2007; 144:930–937.
Article
4. Arenas E, Muñoz D. A new surgical approach for the treatment of conjunctivochalasis: reduction of the conjunctival fold with bipolar electrocautery forceps. Scientific World Journal. 2016; 2016:6589751. DOI:
10.1155/2016/6589751.
Article
5. Qiu W, Zhang M, Xu T, et al. Evaluation of the effects of conjunctivochalasis excision on tear stability and contrast sensitivity. Scientific reports. 2016; 6:37570.
Article
6. Anbesse DH, Kassa T, Kefyalew B, et al. Prevalence and associated factors of pterygium among adults living in Gondar city, Northwest Ethiopia. PLoS One. 2017; 12:e0174450. eCollection 2017. DOI:
10.1371/journal.pone.0174450.
Article
7. Gumus K, Pflugfelder SC. Increasing prevalence and severity of conjunctivochalasis with aging detected by anterior segment optical coherence tomography. Am J Ophthalmol. 2013; 155:238–242.e2.
Article
8. Tong L, Lan W, Shim HS, Hou A. Conjunctivochalasis is the precursor to pterygium. Med Hypotheses. 2013; 81:927–930.
Article
9. Solomon A, Li DQ, Lee SB, Tseng SC. Regulation of collagenase, stromelysin, and urokinase-type plasminogen activator in primary pterygium body fibroblasts by inflammatory cytokines. Invest Ophthalmol Vis Sci. 2000; 41:2154–2163.
10. Ward SK, Wakamatsu TH, Dogru M, et al. The role of oxidative stress and inflammation in conjunctivochalasis. Invest Ophthalmol Vis Sci. 2010; 51:1994–2002.
Article
11. Yu XY, Jian ZY, Wu W, Lu XH. Simultaneous treatment of pterygium complicated with conjunctivochalasis: analysis of pterygium excision and conjunctival autotransplantation combined with sclera fixation. BMC Ophthalmology. 2015; 15:100. DOI:
10.1186/s12886-015-0057-4.
Article
12. Suzuki H, Shiwa T, Oharazawa H, et al. Simultaneous treatment of pterygium and temporal conjunctivochalasis. J Nippon Med Sch. 2013; 80:74–77.
Article
13. Meller D, Tseng SC. Conjunctivochalasis: literature review and possible pathophysiology. Surv Ophthalmol. 1998; 43:225–232.
14. Zhang X, Li Q, Zou H, et al. Assessing the severity of conjunctivochalasis in a senile population: a community-based epidemiology study in Shanghai, China. BMC Public Health. 2011; 11:198. DOI:
10.1186/1471-2458-11-198.
Article
15. Cornelius CR. Recurrence rate and complications of pterygium extended removal followed by extended conjunctival transplant. Cornea. 2017; 36:101–103.
Article
16. Akura J, Kaneda S, Matsuura K, et al. Measures for preventing recurrence after pterygium surgery. Cornea. 2001; 20:703–707.
Article
17. Cho JW, Chung SH, Seo KY, Kim EK. Conjunctival mini-flap technique and conjunctival autotransplantation in pterygium surgery. J Korean Ophthalmol Soc. 2005; 46:1471–1477.
18. Park SY, Han KE, Seo KR. Recurrence after modified mini-flap technique for pterygium surgery. J Korean Ophthalmol Soc. 2012; 53:1419–1424.
Article
19. Alpay A, Uğurbaş SH, Erdoğan B. Comparing techniques for pterygium surgery. Clin Ophthalmol. 2009; 3:69–74.
20. Hirst LW. The Treatment of pterygium. Surv Ophthalmol. 2003; 48:145–180.
Article
21. Hirst LW. Recurrent pterygium surgery using pterygium extended removal followed by extended conjunctival transplant: recurrence rate and cosmesis. Ophthalmology. 2009; 116:1278–1286.
Article
22. Prabhasawat P, Barton K, Burkett G, Tseng SC. Comparison of conjunctival autografts, amniotic membrane grafts, and primary closure for pterygium excision. Ophthalmology. 1997; 104:974–985.
Article
23. Küçükerdönmez C, Akova Y, Altönörs DD. Comparison of conjunctival autograft with amniotic membrane transplantation for pterygium surgery: surgical and cosmetic outcome. Cornea. 2007; 26:407–413.
24. Hirst LW. Cosmesis after pterygium extended removalfollowed by extended conjunctival transplant as assessed by a new, web-based grading system. Ophthalmology. 2011; 118:1739–1746.
25. Meller D, Maskin SL, Pires RT, Tseng SC. Amniotic membrane transplantation for symptomatic conjunctivochalasis refractory to medical treatments. Cornea. 2000; 19:796–803.
Article
26. Fernández-Hortelano A, Moreno-Montañés J, Heras-Mulero H, Sadaba-Echarri LM. Amniotic membrane transplantation with fibrin glue as treatment of refractory conjunctivochalasis. Arch Soc Esp Oftalmol. 2007; 82:571–574.
27. Kheirkhah A, Casas V, Blanco G, et al. Amniotic membrane transplantation with fibrin glue for conjunctivochalasis. Am J Ophthalmol. 2007; 144:311–313.
Article
28. Georgiadis NS, Terzidou CD. Epiphora caused by conjunctivochalasis: treatment with transplantation of preserved human amniotic membrane. Cornea. 2001; 20:619–621.
29. Kim SH, Oh JH, Do JR, et al. A Comparison of anchored conjunctival rotation flap and conjunctival autograft techniques in pterygium surgery. Cornea. 2013; 32:1578–1581.
Article